|
1
|
Richters A, Aben KKH and Kiemeney LALM:
The global burden of urinary bladder cancer: An update. World J
Urol. Nov 1–2019.(Epub ahead of print). PubMed/NCBI
|
|
2
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma S, Ksheersagar P and Sharma P:
Diagnosis and treatment of bladder cancer. Am Fam Physician.
80:717–723. 2009.PubMed/NCBI
|
|
4
|
Allory Y, Beukers W, Sagrera A, Flández M,
Marqués M, Márquez M, van der Keur KA, Dyrskjot L, Lurkin I,
Vermeij M, et al: Telomerase reverse transcriptase promoter
mutations in bladder cancer: High frequency across stages,
detection in urine, and lack of association with outcome. Eur Urol.
65:360–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS,
Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, et al: Predictive value
of progression-related gene classifier in primary non-muscle
invasive bladder cancer. Mol Cancer. 9:32010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Milowsky MI, Rumble RB, Booth CM, Gilligan
T, Eapen LJ, Hauke RJ, Boumansour P and Lee CT: Guideline on
Muscle-Invasive and Metastatic Bladder Cancer (European Association
of Urology Guideline): American Society of Clinical Oncology
Clinical Practice Guideline Endorsement. J Clin Oncol.
34:1945–1952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quirk JT and Kupinski JM: Chronic
infection, inflammation, and epithelial ovarian cancer. Med
Hypotheses. 57:426–428. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Liang Y and He C: Anticancer
activities and mechanisms of heat-clearing and detoxicating
traditional Chinese herbal medicine. Chin Med. 12:202017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Man S, Gao W, Wei C and Liu C: Anticancer
drugs from traditional toxic Chinese medicines. Phytother Res.
26:1449–1465. 2012.PubMed/NCBI
|
|
11
|
Lee MS, Yuet-Wa JC, Kong SK, Yu B,
Eng-Choon VO, Nai-Ching HW, Chung-Wai TM and Fung KP: Effects of
polyphyllin D, a steroidal saponin in Paris polyphylla, in
growth inhibition of human breast cancer cells and in xenograft.
Cancer Biol Ther. 4:1248–1254. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He H, Zheng L, Sun YP, Zhang GW and Yue
ZG: Steroidal saponins from Paris polyphylla suppress
adhesion, migration and invasion of human lung cancer A549 cells
via down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev.
15:10911–10916. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao X, Zou J, Bui-Nguyen TM, Bai P, Gao
L, Liu J, Liu S, Xiao J, Chen X, Zhang X, et al: Paris saponin II
of Rhizoma Paridis - a novel inducer of apoptosis in human ovarian
cancer cells. Biosci Trends. 6:201–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Commission CP: Pharmacopoeia of The
People's Republic of China. 1:(1st). People's Medical Publishing
House. (Beijing). 2015.
|
|
15
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao T, Zhong W, Zhao J, Qian B, Liu H,
Chen S, Qiao K, Lei Y, Zong S, Wang H, et al: Polyphyllin I
suppresses the formation of vasculogenic mimicry via
Twist1/VE-cadherin pathway. Cell Death Dis. 9:9062018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Huang P, Liu X, Xiang Y, Zhang T,
Wu Y, Xu J, Sun Z, Zhen W, Zhang L, et al: Polyphyllin I inhibits
growth and invasion of cisplatin-resistant gastric cancer cells by
partially inhibiting CIP2A/PP2A/Akt signaling axis. J Pharmacol
Sci. 137:305–312. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu H, Meng Q, Lei T and Zhang M:
Nucleophosmin1 associated with drug resistance and recurrence of
bladder cancer. Clin Exp Med. 15:361–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fankhauser CD and Mostafid H: Prevention
of bladder cancer incidence and recurrence: Nutrition and
lifestyle. Curr Opin Urol. 28:88–92. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsiao WL and Liu L: The role of
traditional Chinese herbal medicines in cancer therapy - from TCM
theory to mechanistic insights. Planta Med. 76:1118–1131. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chow SE, Chang YL, Chuang SF and Wang JS:
Wogonin induced apoptosis in human nasopharyngeal carcinoma cells
by targeting GSK-3β and ΔNp63. Cancer Chemother Pharmacol.
68:835–845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Lv J, Lei X, Li S, Zhang Y, Meng
L, Xue R and Li Z: Baicalein reduces the invasion of glioma cells
via reducing the activity of p38 signaling pathway. PLoS One.
9:e903182014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weifeng T, Feng S, Xiangji L, Changqing S,
Zhiquan Q, Huazhong Z, Peining Y, Yong Y, Mengchao W, Xiaoqing J,
et al: Artemisinin inhibits in vitro and in vivo
invasion and metastasis of human hepatocellular carcinoma cells.
Phytomedicine. 18:158–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fidler IJ and Kripke ML: The challenge of
targeting metastasis. Cancer Metastasis Rev. 34:635–641. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF beta induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Halbersztadt A, Haloń A, Pajak J,
Robaczyński J, Rabczynski J and St Gabryś M: The role of matrix
metalloproteinases in tumor invasion and metastasis. Ginekol Pol.
77:63–71. 2006.(In Polish). PubMed/NCBI
|
|
34
|
Klein G, Vellenga E, Fraaije MW, Kamps WA
and de Bont ES: The possible role of matrix metalloproteinase
(MMP)-2 and MMP-9 in cancer, e.g., acute leukemia. Crit Rev Oncol
Hematol. 50:87–100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao N, Ren K, Wang Y, Jin Q, Lu X, Lu Y,
Jiang C, Zhang D, Lu J, Wang C, et al: Paris polyphylla
suppresses proliferation and vasculogenic mimicry of human
osteosarcoma cells and inhibits tumor growth in vivo. Am J Chin
Med. 45:575–598. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang CW and Tai CJ, Choong CY, Lin YC, Lee
BH, Shi YC and Tai CJ: Aqueous extract of Paris polyphylla
(AEPP) inhibits ovarian cancer via suppression of peroxisome
proliferator activated receptor gamma coactivator (PGC) 1alpha.
Molecules. 21:7272016. View Article : Google Scholar
|
|
37
|
Wang W, Dong X, You L, Sai N, Leng X, Yang
C, Yin X and Ni J: Apoptosis in HepaRG and HL-7702 cells inducted
by polyphyllin II through caspases activation and cell-cycle
arrest. J Cell Physiol. 234:7078–7089. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gu L, Feng J, Xu H, Luo M and Su D:
Polyphyllin I inhibits proliferation and metastasis of ovarian
cancer cell line HO 8910PM in vitro. J Tradit Chin Med.
33:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lou W, Chen Y, Zhu KY, Deng H, Wu T and
Wang J: Polyphyllin I overcomes EMT-associated resistance to
erlotinib in lung cancer cells via IL-6/STAT3 pathway inhibition.
Biol Pharm Bull. 40:1306–1313. 2017. View Article : Google Scholar : PubMed/NCBI
|
